China Sanjiang Fine Chemicals Company Limited
HKEX:2198.HK
1.88 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13,128.4 | 8,817.875 | 9,498.708 | 8,322.716 | 9,190.893 | 9,585.859 | 8,897.143 | 6,647.019 | 4,966.427 | 3,636.8 | 3,940.471 | 2,521.448 | 2,078.188 | 1,582.526 | 1,285.533 |
| Cost of Revenue
| 12,934.064 | 8,888.25 | 8,864.189 | 6,692.606 | 8,133.347 | 8,640.434 | 7,821.291 | 5,721.998 | 4,836.839 | 3,419.299 | 3,402.187 | 1,991.16 | 1,644.844 | 1,222.362 | 929.212 |
| Gross Profit
| 194.336 | -70.375 | 634.519 | 1,630.11 | 1,057.546 | 945.425 | 1,075.852 | 925.021 | 129.588 | 217.501 | 538.284 | 530.288 | 433.344 | 360.164 | 356.321 |
| Gross Profit Ratio
| 0.015 | -0.008 | 0.067 | 0.196 | 0.115 | 0.099 | 0.121 | 0.139 | 0.026 | 0.06 | 0.137 | 0.21 | 0.209 | 0.228 | 0.277 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 197.702 | 197.466 | 269.715 | 393.208 | 276.934 | 314.875 | 251.19 | 309.268 | 174.229 | 115.402 | 130.715 | 91.849 | 72.861 | 63.51 | 37.473 |
| Selling & Marketing Expenses
| 3.761 | 2.97 | 12.41 | 25.33 | 34.631 | 25.515 | 25.801 | 26.502 | 25.092 | 10.609 | 18.499 | 1.845 | 4.576 | 2.064 | 2.966 |
| SG&A
| 201.463 | 195.301 | 282.189 | 416.749 | 313.38 | 352.463 | 285.799 | 344.382 | 208.587 | 134.121 | 153.645 | 93.694 | 77.437 | 65.574 | 40.439 |
| Other Expenses
| 20.566 | 18.706 | 31.492 | 26.31 | 24.683 | 24.852 | 19.619 | 90.798 | 9.75 | 21.356 | 8.334 | -38.161 | 147.151 | -43.401 | -20.868 |
| Operating Expenses
| 73.901 | 232.837 | 135.177 | 260.017 | 288.239 | 417.02 | 252.111 | 108.005 | 188.129 | 140.948 | 66.857 | 13.322 | 80.446 | 22.173 | 19.571 |
| Operating Income
| -35.476 | -811.83 | -104.884 | 1,070.374 | 709.349 | -181.408 | 16.423 | 298.693 | -604.464 | -317.539 | 54.866 | 619.826 | 495.992 | 337.661 | 336.75 |
| Operating Income Ratio
| -0.003 | -0.092 | -0.011 | 0.129 | 0.077 | -0.019 | 0.002 | 0.045 | -0.122 | -0.087 | 0.014 | 0.246 | 0.239 | 0.213 | 0.262 |
| Total Other Income Expenses Net
| 55.683 | 447.347 | 547.066 | 321.675 | -52.306 | 571.183 | 727.423 | 394.122 | 439.5 | 464.909 | 630.905 | -62.892 | -32.438 | -19.087 | -32.915 |
| Income Before Tax
| 20.207 | -364.483 | 442.182 | 1,392.049 | 657.043 | 389.775 | 743.846 | 692.815 | -164.964 | 147.37 | 685.771 | 556.934 | 463.554 | 318.574 | 303.835 |
| Income Before Tax Ratio
| 0.002 | -0.041 | 0.047 | 0.167 | 0.071 | 0.041 | 0.084 | 0.104 | -0.033 | 0.041 | 0.174 | 0.221 | 0.223 | 0.201 | 0.236 |
| Income Tax Expense
| -23.927 | 10.029 | 66.029 | 177.852 | 81.096 | 88.583 | 120.709 | 93.964 | 62.268 | 16.564 | 81.011 | 89.924 | 58.369 | 52.263 | 43.673 |
| Net Income
| 91.477 | -307.88 | 380.611 | 1,122.931 | 550.474 | 398.915 | 690.793 | 552.614 | -145.502 | 132.78 | 605.131 | 466.776 | 404.769 | 266.126 | 242.075 |
| Net Income Ratio
| 0.007 | -0.035 | 0.04 | 0.135 | 0.06 | 0.042 | 0.078 | 0.083 | -0.029 | 0.037 | 0.154 | 0.185 | 0.195 | 0.168 | 0.188 |
| EPS
| 0.078 | -0.26 | 0.32 | 0.95 | 0.46 | 0.39 | 0.67 | 0.56 | -0.15 | 0.13 | 0.61 | 0.47 | 0.4 | 0.35 | 0.37 |
| EPS Diluted
| 0.078 | -0.26 | 0.32 | 0.95 | 0.46 | 0.39 | 0.67 | 0.56 | -0.15 | 0.13 | 0.61 | 0.47 | 0.4 | 0.35 | 0.37 |
| EBITDA
| 779.117 | -287.963 | 388.691 | 1,637.779 | 1,297.226 | 359.417 | 565.647 | 913.268 | -169.079 | -147.715 | 220.646 | 724.704 | 588 | 409.78 | 416.575 |
| EBITDA Ratio
| 0.059 | -0.033 | 0.041 | 0.197 | 0.141 | 0.037 | 0.064 | 0.137 | -0.034 | -0.041 | 0.056 | 0.287 | 0.283 | 0.259 | 0.324 |